Volumetric
Volumetric is a YC Winter 2020 (W20) company. Based in Houston, TX, USA. Team of 5.
About Volumetric
Summary
Volumetric builds 3D-bioprinted human tissues with embedded vascular networks, serving pharmaceutical and drug development teams that need to test compound safety and efficacy. Patient cells taken from a biopsy are added to the printed tissue, and drug compounds are delivered through the vessel network to replicate how drugs move through the human body. The technology replaces animal models and conventional in-vitro assays with patient-specific tissue that more accurately predicts human response.
Go-to-market
Pharmaceutical and biotech companies are the primary buyers, procuring patient-specific tissue models for preclinical drug safety and efficacy screening.
From the Y Combinator listing
Volumetric builds living multicellular tissues with a focus on the…
About Us Volumetric is a recognized world leader in building living multicellular tissues, with a focus on replicating discrete functions of the human body for basic mechanistic biology, laboratory testing and screening, and drug development. Founded in 2018 by Bagrat Grigoryan and Jordan Miller as a spin-out from Rice University, the full potential of our work is to build whole human organ replacements for patients, made from their own cells. Our Technology and Approach We have invented a suite of breakthrough 3D bioprinting technologies, featured on the cover of Science, that can build human tissue with complex blood vessel networks. We are leveraging this technology in the short term to build patient-specific tissues for drug safety and efficacy testing. Patient cells are taken from a biopsy, added to our proprietary 3D printed tissues, and then drug compounds are injected through the blood vessel network to mimic actual drug delivery in humans. Our vision is that our technology will provide rigorous, reproducible, and predictive outcomes for patients, resulting in drastically improved outcomes for diseases like cancer. More broadly, we see the full potential of our mission as being able to produce functional tissue and organ replacements for diseased or damaged vital organs in the body such as the lung, liver, pancreas, kidney, and heart.
Facts
- Healthcare / Healthcare -> Industrial Bio
- Houston, TX, USA
- 5
- Acquired
- Early
Founders (2)
- Bagrat Grigoryan
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works